---
layout: minimal-medicine
title: Meningococcal Polysaccharide (Groups C and Y) + Haemophilus B Tetanus Toxoid Conjugate Vaccine
---

# Meningococcal Polysaccharide (Groups C and Y) + Haemophilus B Tetanus Toxoid Conjugate Vaccine
### Generic Name
Meningococcal Polysaccharide (Groups C and Y) + Haemophilus B Tetanus Toxoid Conjugate Vaccine

### Usage
This vaccine is used to actively immunize against invasive diseases caused by *Neisseria meningitidis* serogroups C and Y, and *Haemophilus influenzae* type B.  It works by stimulating the body's immune system to produce antibodies that fight off these bacteria, thus preventing infection.  This vaccine is primarily used in infants and young children to protect them against these potentially life-threatening bacterial infections.


### Dosage
This vaccine is **not indicated for adults**.

**Pediatric Dosage:**

The recommended dosage for children aged 6 weeks to 18 months is a 0.5 mL intramuscular (IM) injection.  A total of four doses are given according to the following schedule: at 2, 4, 6, and 12 to 15 months of age. The first dose can be given as early as 6 weeks, and the last dose as late as 18 months. The vaccine should be administered in the anterolateral aspect of the thigh in infants, and in the deltoid muscle of the arm in children aged 12 to 18 months.  It's crucial to follow the recommended schedule precisely for optimal protection.  This vaccine should not be administered intravenously (IV) or subcutaneously (SubQ).  It should also not be co-administered with other Hib-containing vaccines.


### Side Effects
**Common Side Effects (Occurring in more than 10% of recipients):**

* Irritability
* Drowsiness
* Decreased appetite
* Pain at the injection site
* Erythema (redness) at the injection site
* Swelling at the injection site
* Fever (≥100.4°F/38°C)


**Less Common, but Serious Side Effects (Occurring in less than 1% of recipients, based on post-marketing surveillance and case reports):**

* Anaphylactoid reaction
* Anaphylaxis
* Angioedema
* Apnea
* Hypersensitivity reaction
* Hypotonic-hyporesponsive episode
* Induration at the injection site
* Seizure (with or without fever)
* Skin rash
* Extensive swelling of the injected limb
* Syncope (fainting)
* Urticaria (hives)
* Vasodepressor syncope


**Important Note:** Seek immediate medical attention if you experience any serious adverse reaction after receiving this vaccine.


### How it Works
This vaccine is a conjugate vaccine, meaning it combines a polysaccharide (from the bacteria's surface) with a protein (tetanus toxoid) to enhance the immune response. The polysaccharide component targets the bacteria, while the protein acts as a carrier to improve antibody production. Upon vaccination, the immune system recognizes the polysaccharides and produces antibodies specific to *Neisseria meningitidis* serogroups C and Y and *Haemophilus influenzae* type B.  These antibodies then circulate in the bloodstream and provide protection against future infections by these bacteria.

### Precautions
**Contraindications:**

* Severe allergic reaction to any meningococcal, *H. influenzae* type B, or tetanus toxoid-containing vaccine, or any component of this vaccine.


**Warnings:**

* Increased risk of anaphylactoid/hypersensitivity reactions, shoulder injury related to vaccine administration (SIRVA), and syncope.


**Use with Caution:**

* In patients with a history of bleeding disorders.
* In patients with Guillain-Barré syndrome.
* In patients receiving anticoagulant therapy.
* Immunization should be delayed if the child has an acute febrile illness.


### FAQs

**Q: How long does the protection from this vaccine last?**  A:  The duration of protection provided by this vaccine is not fully established, and further studies are needed to determine the length of immunity.

**Q: What should I do if my child develops a high fever after vaccination?** A:  Consult your pediatrician.  Antipyretics (fever-reducing medication) may be used to manage fever and discomfort.

**Q: Can this vaccine be given with other vaccines?** A:  The Advisory Committee on Immunization Practices (ACIP) recommends simultaneous administration of age-appropriate vaccines (live or inactivated) at the same clinic visit unless contraindications exist. However, it should *not* be co-administered with other Hib-containing vaccines.

**Q: What should I do if my child faints after vaccination?** A: Keep your child in a supine or Trendelenburg position to restore adequate cerebral perfusion.  Seek medical attention if needed.

**Q:  How should I store this vaccine?** A:  Follow the storage instructions provided by your healthcare provider or pharmacist.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional for any health concerns or before making any decisions related to your or your child's health or treatment.  This summary is based on available information and may not include all possible side effects, precautions, or interactions. Always refer to the official prescribing information for the most up-to-date and complete details.
